Telehealth Weight Loss/GLP-1 Prescribing: What Psychiatrists Can Do in New York

You’re a psychiatrist or PMHNP watching half your patients struggle with weight gain from the very medications keeping them stable. You see them develop metabolic syndrome. You watch their self-esteem tank. And now patients are asking: ‘Can you prescribe Ozempic?’

The short answer: Yes, in most cases. But the real question isn’t can you — it’s should you, and more importantly, how do you do it right from a regulatory, clinical, and business standpoint?

This isn’t about jumping on the GLP-1 bandwagon for revenue. It’s about recognizing that metabolic and mental health are inseparable, and that you’re already managing the metabolic fallout from psychiatric medications. Let’s talk about what it actually takes to add weight-loss prescribing to your practice in 2026.

Why Psychiatrists Are Uniquely Positioned for Weight Management

Here’s what most people miss: You’re already doing metabolic medicine.

Every time you prescribe an atypical antipsychotic, you’re monitoring glucose and lipids. You’re fielding calls about 30-pound weight gain on mirtazapine. You’re explaining why that SSRI might be contributing to their plateau. You understand the neurobiology of appetite, reward pathways, and the gut-brain axis better than most primary care docs.

The rise of GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) has blurred the lines between ‘psychiatric’ and ‘metabolic’ treatment. These drugs don’t just cause weight loss — emerging research shows they may reduce binge-eating impulses, dampen substance cravings, and potentially improve mood independent of weight loss.

Dr. Elliott Lewis, a psychiatrist board-certified in obesity medicine, puts it plainly: ‘If we truly understand that metabolic and mental health systems are inseparable, then psychiatrists being involved in metabolic treatment makes complete sense.’

The clinical rationale is there. But can you legally prescribe these medications, and what hoops do you need to jump through?

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Legal Landscape: Who Can Prescribe What

Psychiatrists (MD/DO): Full Authority with Caveats

As a physician, you have unrestricted prescriptive authority for FDA-approved weight-loss medications in all 50 states. Your DEA license and state medical license cover everything from Schedule IV appetite suppressants (phentermine) to non-controlled GLP-1s (Wegovy, Saxenda, Mounjaro).

However, having legal authority doesn’t mean automatic compliance. Many states impose specific requirements for how you prescribe weight-loss drugs:

Florida requires:

• Documented BMI ≥30 (or ≥27 with comorbidity)
• Comprehensive physical exam (can be delegated to an APRN/PA but must be documented)
• Written informed consent
• Follow-up visits every 3 months minimum
• Providing the state’s ‘Weight-Loss Consumer Bill of Rights’

New Jersey mandates:

• Comprehensive workup including psychiatric assessment
• Lab tests to rule out secondary causes
• Documented nutritional counseling, exercise plan, and behavior modification recommendations
• Regular ongoing monitoring

Virginia requires:

• Initial physical exam
• Follow-up within 30 days of starting medication
• Documented diet and exercise program

The pattern: States want to prevent ‘pill mill’ weight-loss clinics. They want proof you’re treating the whole patient, not just writing scripts.

Scope-of-practice question: Is obesity treatment ‘outside your scope’ as a psychiatrist? Not if you’re competent. Many psychiatrists are now pursuing American Board of Obesity Medicine (ABOM) certification — which explicitly welcomes any physician specialty. After ~60 hours of obesity-related CME and passing the exam, you have documented proficiency that addresses any scope concerns.

PMHNPs: State-by-State Patchwork

This is where it gets complicated. Your ability to prescribe weight-loss medications as a psychiatric nurse practitioner depends entirely on your state’s scope-of-practice laws.

Full Practice Authority States (24+ states including Washington, Oregon, Arizona, New Mexico, Maryland, Connecticut, Rhode Island, etc.):

• You can prescribe independently after meeting state requirements
• No physician collaboration needed for prescriptive authority
• You control your own formulary

Reduced Practice States (includes New York, Illinois after experience threshold):

• Initial physician collaboration required
• After specific hours (NY: 3,600 hours; IL: 4,000 hours), you may gain independent authority
• Prescribing may still require MD relationship

Restricted Practice States (includes Texas, Florida, Pennsylvania, California):

• Always require physician collaboration/supervision
• Must have written protocols or prescriptive authority agreements
• Physician oversight mandatory for all prescribing

The Florida/Texas reality for PMHNPs:

In Florida, even ‘autonomous’ NPs (which don’t include psychiatric NPs) cannot independently prescribe controlled substances for weight loss. You need a supervising physician protocol. Period.

In Texas, you need a Prescriptive Authority Agreement with a Texas-licensed physician that specifically authorizes weight-loss medications. Your collaborating physician must review charts and meet with you monthly. One physician can supervise maximum 7 NPs in non-hospital settings.

The hidden barrier even in independent states: Some insurers and pharmacies hesitate to process GLP-1 prescriptions from NPs without physician involvement — not because it’s illegal, but because of internal policies around high-cost drugs. You might be legally allowed to prescribe Wegovy in Washington, but still hit friction at the pharmacy benefit manager level.

The Telehealth Prescribing Minefield

Here’s where providers get burned: Federal telehealth waivers don’t override state restrictions.

The DEA extended COVID-era flexibilities through December 31, 2025 (and likely beyond), allowing controlled substance prescribing via telehealth without an initial in-person visit at the federal level. Great news, right?

Not so fast. State laws can — and do — impose stricter requirements.

Florida explicitly prohibits prescribing controlled substances via telehealth except for:

• Psychiatric disorder treatment
• Inpatient/hospice care
• Acute pain treatment

Weight loss is not on the exception list. That means you cannot prescribe phentermine (Schedule IV) via telehealth to a Florida patient, even though federal law allows it. Violate this and you’re risking your Florida license.

(GLP-1s like semaglutide are non-controlled, so they’re fine via telehealth in Florida — but you still must meet Florida’s obesity prescribing rules: documented exam, BMI criteria, quarterly follow-ups.)

Alabama similarly requires an initial in-person exam before any controlled substance prescription.

The 8-state problem: About 8 states maintain telehealth prescribing restrictions stricter than federal law. These include Florida, Alabama, Idaho, and South Carolina. If you’re on a national telehealth platform, you need state-specific protocols or you’ll geofence certain services out of those states.

Best practice for telehealth weight-loss prescribing:

• Conduct initial visit via live video (not async questionnaire)
• Document comprehensive history including psychiatric screening
• Review or order recent labs (CBC, CMP, TSH, lipids, HbA1c)
• Calculate and document BMI
• Have patient self-report weight/BP or arrange local vital checks
• Provide written education on risks, benefits, lifestyle modifications
• Schedule mandatory follow-ups per state requirements (monthly in VA, quarterly in FL, etc.)
• Check Prescription Drug Monitoring Program before any controlled substance

The Mississippi case study: In 2023, a doctor’s license was suspended for prescribing Ozempic through an instant-messaging platform with no audio or video. The board ruled he failed to establish a proper patient relationship. Don’t be that provider.

The Economics: What This Actually Costs (and Pays)

Let’s talk real numbers, because this matters to your practice viability.

Patient Acquisition Reality

Forget the fantasy of ‘$30-50 per patient’ acquisition costs you might see in some marketing materials. That’s not reality for psychiatric or weight-loss patients.

DIY marketing actual costs:

• Google Ads for ‘weight loss doctor near me’: $15-40+ per click
• Converting clicks to booked appointments: maybe 5-10%
• Realistic cost per booked patient through PPC: $200-400+
• Psychology Today directory: $30/month but you’re competing with 500 other providers
• Zocdoc: $35-100+ per booking plus monthly subscription fees
• SEO: 6-12 months of consistent investment before meaningful patient flow

Total monthly marketing spend for a solo practitioner trying to build a weight-loss practice: $3,000-5,000/month with uncertain results.

Most providers don’t have the expertise, budget, or patience for this. You’ll spend six months optimizing landing pages and burning through ad spend before seeing ROI.

Platform Economics: The Klarity Model

This is where telehealth platforms make sense. Instead of gambling $4,000/month on marketing channels with no guarantees, you pay only when you see patients.

Platforms like Klarity Health use a pay-per-appointment model similar to Zocdoc, but with key advantages:

• Pre-qualified patients already matched to your specialty and availability
• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you actually see patients

The economic reality: Instead of spending $3,000-5,000/month on marketing with uncertain patient volume, you pay a standard listing fee per new patient consultation. That’s guaranteed ROI vs. gambling on Google Ads.

Reimbursement: What You’ll Actually Get Paid

For the medication itself:

Insurance coverage for GLP-1 weight-loss drugs has exploded in the last two years. Most commercial plans now cover Wegovy, Saxenda, or Mounjaro with prior authorization showing:

• BMI ≥30 or ≥27 with comorbidities
• Documentation of lifestyle interventions
• Prescriber attestation of medical necessity

Medicare coverage is changing the game: As of late 2025, Medicare announced it will begin covering anti-obesity medications — a monumental shift affecting millions of beneficiaries. By 2026, expect broader Medicaid coverage as well.

The catch: Prior authorizations are detailed. Insurers want proof you’re doing comprehensive management, not just prescribing. You’ll document diet counseling, exercise recommendations, behavioral interventions. This aligns perfectly with state requirements like New Jersey’s mandate for multi-modal treatment.

For your clinical visits:

Standard E/M codes apply. Medicare/most insurers pay:

• Initial psychiatric evaluation (90792): ~$200
• Established E/M visit, 15-20 min (99213): ~$75-100
• Established E/M visit, 25-30 min (99214): ~$120-150

Psychiatrists (MD/DO): Reimbursed at 100% of physician fee schedule

PMHNPs: Reimbursed at 85% of physician rates under Medicare when billing under your NPI. Some states do better — Illinois Medicaid reimburses NPs at 100% of physician rates.

Telehealth parity: In California, New York, Illinois, and Pennsylvania, state laws require commercial insurers to reimburse telehealth visits at the same rate as in-person. Medicare continues telehealth mental health flexibilities with no geographic restrictions.

Revenue model example:

• 20 weight-management patients/month
• Average 2 visits per patient (initial + follow-ups): 40 visits
• Average reimbursement $110/visit
• Gross revenue: $4,400/month from visits alone

Add medication management for your existing psychiatric patients who develop metabolic issues, and it’s a natural practice extension with better patient outcomes.

The Clinical Reality: Should You Do This?

Here’s the honest assessment.

You should consider weight-loss prescribing if:

• You’re already managing patients on weight-positive psych meds (antipsychotics, mood stabilizers, some antidepressants)
• You’re comfortable monitoring metabolic parameters (you probably already do this)
• You’re willing to coordinate with PCPs, endocrinology when needed
• You can commit to regular follow-ups and documentation
• You understand this is medication management plus lifestyle counseling, not just writing scripts

You should NOT just jump in if:

• You view this solely as a revenue grab
• You’re not willing to do the training (at minimum, substantial CME in obesity medicine; ideally ABOM certification)
• You can’t meet your state’s follow-up requirements
• You’re operating via ‘questionnaire-only’ telehealth (that’s asking for board action)

The scope question answered:

Is prescribing GLP-1s within a psychiatrist’s scope? Yes — if you’re competent. Scope is about training and competency, not just specialty title. If you gain the knowledge (through CME, mentorship, or ABOM certification), you’re practicing within an acceptable scope extension.

As Dr. Lewis notes: ‘It’s not about expanding scope to grab more patients. It’s about offering more integrated care to existing patients who will benefit. If scope is about competency rather than tradition, then prescribing medications that affect both metabolic and mental health falls within a reasonable scope for psychiatrists specializing in metabolic-psychiatric care.’

Collaboration is key: Even as a psychiatrist with full authority, communicate with the patient’s PCP. Don’t usurp necessary medical workups. Refer to endocrinology or cardiology when you hit the limits of your expertise (e.g., patient with complex diabetes needing insulin adjustment). Document that you’re providing comprehensive care, not siloed prescribing.

State-Specific Action Items

California

• MDs: Prescribe freely; follow standard clinical guidelines
• PMHNPs: Need physician protocols until 2026 when AB 890 full independence takes effect; cannot independently prescribe controlled substances for weight loss yet
• Watch: Corporate Practice of Medicine — even independent NPs need physician-owned practice structure for clinics
• Telehealth: Wide open; strong parity laws

Texas

• MDs: Full authority; phentermine allowed (not Schedule II stimulants for weight loss)
• PMHNPs: MUST have Prescriptive Authority Agreement with TX physician; monthly oversight meetings required
• Physician supervision ratio: Max 1:7 outside hospitals
• PMP checks required for controlled substances
• Telehealth: Allowed for weight loss; document proper evaluation

Florida

• MDs: Full authority BUT must meet obesity prescribing rules (BMI criteria, informed consent, quarterly follow-ups, Consumer Bill of Rights)
• PMHNPs: Must have physician protocol; cannot independently prescribe even as ‘autonomous’ APRN for weight loss controlled substances
• Clinic requirement: Health Care Clinic Act applies — need physician medical director
• Telehealth RESTRICTION: Cannot prescribe phentermine or other controlled substances via telehealth (not on exception list); GLP-1s OK
• Watch: Board enforcement is active — don’t miss 3-month follow-ups

New York

• MDs: Full authority; no special state obesity rules
• PMHNPs: Need collaboration initially; after 3,600 hours can practice independently
• I-STOP: Must check PMP before controlled substance prescriptions
• Telehealth: Excellent parity laws; no state CS prescribing restrictions beyond federal

Pennsylvania

• MDs: Full authority
• PMHNPs: Must have Collaboration Agreement (no FPA yet); physician’s name on prescriptions; chart review required
• Watch: FPA legislation may eventually pass — stay tuned
• Telehealth: Allowed; mental health parity but not yet full payment parity for all services

Illinois

• MDs: Full authority
• PMHNPs: Can achieve Full Practice Authority after 4,000 hours + 250 CE hours; independent prescribing including controlled substances (with some Schedule II consultation requirements)
• Sweet spot: IL Medicaid pays NPs at 100% physician rates
• Telehealth: Strong parity; supportive environment
• PMP: Must register and check for controlled substances

Making the Business Case

Let’s get practical about whether this makes sense for your practice.

Startup investment needed:

• Training: ABOM prep course (~$500-1,000) + exam fee ($785) if pursuing certification; or 20-40 hours CME in obesity medicine (~$500-1,500)
• Collaborative physician (if NP in restricted state): $2,000-6,000/month depending on state and arrangement
• EHR templates: 10-20 hours building proper documentation templates for weight management visits (BMI, informed consent, follow-up protocols)
• Telehealth platform: $0 if using Klarity (included); $100-300/month if separate platform
• Insurance credentialing: 2-4 months lead time; may need assistance ($500-2,000 if outsourced)

Ongoing costs:

• Platform fees: Pay-per-appointment model (only when you see patients) vs. fixed monthly marketing spend
• Time: 20-30 min initial visits, 15 min follow-ups
• Liability insurance: Verify your policy covers obesity medication prescribing (most psych policies do; confirm)
• PMP checks: 2-5 min per patient for controlled substances (required)

Revenue potential:

• Conservative: 10 new weight-loss patients/month, 80% retention, average 3 visits/patient lifetime

• Month 1: 10 initial visits × $150 avg = $1,500

• Month 3: (10 + 10 + 10 new + 16 follow-ups) × avg $120 = ~$5,500/month stabilized

• Moderate growth: 25 new patients/month with platform patient flow

• Month 6 stabilized: ~$12,000-15,000/month revenue from weight management visits

The integration advantage: You’re not building a standalone weight-loss practice. You’re adding a service for existing psych patients who need it (medication-induced weight gain) AND attracting new patients who may also benefit from psychiatric care (depression + obesity overlap is ~50%).

Break-even timeline:

• Using pay-per-appointment platform model: Immediate positive ROI (you only pay when generating revenue)
• DIY marketing model: 6-12 months if done well; potentially never if you don’t have marketing expertise

The Platform Advantage: Why Klarity Makes Sense

Here’s why joining a platform like Klarity Health is the smart move for most psychiatrists and PMHNPs considering weight-loss prescribing:

1. Patient acquisition is handledYou don’t spend months building SEO, testing ad campaigns, or competing on Psychology Today. Klarity matches pre-qualified patients to your availability and specialty.

2. Zero upfront marketing riskPay-per-appointment model means you’re not gambling $4,000/month hoping for patient volume. You pay only when you actually see a patient.

3. Compliance infrastructure built-inTelehealth platform, documentation templates, state-specific protocols, PDMP integration, prior authorization support — all handled.

4. Both insurance and cash-payAccept insurance (higher volume, lower patient cost barrier) or cash-pay (simpler billing, faster payment) or both.

5. You control your scheduleSet your availability. See 5 patients/week or 30. Ramp up or down based on your capacity.

6. Support for state-specific requirementsMulti-state credentialing assistance, collaborative physician network in states requiring it (for NPs), updated protocols as regulations change.

The alternative is spending 6-12 months building your own telehealth infrastructure, hiring marketing help, learning Google Ads, getting credentialed with 5-10 insurance panels, building intake workflows, setting up billing… all while seeing zero patients and burning cash.

Or you join a platform, complete credentialing, and start seeing patients within 4-6 weeks with zero marketing spend.

The math is simple: Would you rather spend $30,000-50,000 in the first year on DIY practice building with uncertain results, or pay per-appointment fees only when you’re generating revenue?

Your Next Steps

If you’re serious about adding weight-loss prescribing to your practice in 2026:

Step 1: Verify your state requirements

• Check if you’re in a restricted state (need collaborating physician if NP)
• Review state-specific obesity prescribing rules (follow-up frequency, informed consent, etc.)
• Confirm telehealth controlled substance rules if you plan to prescribe phentermine

Step 2: Get trained

• Minimum: 20 hours CME in obesity medicine, GLP-1 pharmacology, metabolic complications
• Ideal: Pursue ABOM certification (demonstrates competency, addresses scope concerns)
• Review current clinical guidelines (Endocrine Society, Obesity Medicine Association)

Step 3: Build your clinical protocols

• Documentation templates (BMI calculation, informed consent, lifestyle counseling notes)
• PMP check workflows for controlled substances
• Follow-up scheduling (set recurring 3-month or 1-month appointments per state requirements)
• Referral criteria (when to loop in endocrinology, cardiology, registered dietitian)

Step 4: Choose your business model

• Platform model (recommended): Join Klarity Health — complete credentialing, start seeing matched patients within 4-6 weeks, pay only per appointment
• DIY model: Budget $30K+ first year, hire marketing, build infrastructure, expect 6-12 month ramp

Step 5: Start conservative, scale smart

• Begin with existing psych patients who have medication-induced weight gain (natural fit)
• Add GLP-1s to your formulary for appropriate candidates
• Expand to broader weight management as you gain competency
• Track outcomes (patient weight loss, A1c improvement, medication adherence)

The Bottom Line

Can psychiatrists and PMHNPs prescribe weight-loss medications? Absolutely.

Should you? If you’re committed to doing it right, it’s a natural evolution of integrated psychiatric-metabolic care.

The regulatory landscape is navigable but requires diligence. State-by-state rules matter. Telehealth creates opportunities but also compliance traps. Training and competency are non-negotiable.

The business case is strong — especially using a platform model that removes patient acquisition risk. The clinical case is even stronger: your patients need metabolic intervention, and you’re already managing their psychiatric medications that often caused the weight gain in the first place.

The field of psychiatry is evolving toward treating the whole patient. Weight management isn’t a side hustle — it’s integrated care for a patient population where obesity rates are 2-3x higher than the general population, where metabolic syndrome shortens lives by a decade, and where medication-induced weight gain drives non-adherence to life-saving psychiatric treatment.

Ready to explore adding weight-loss prescribing to your practice? Join Klarity Health’s provider network and start seeing matched patients within weeks — no marketing spend, no patient acquisition risk, just medicine.

FAQ

Can a psychiatrist legally prescribe Wegovy or Ozempic?

Yes. Psychiatrists (MD/DO) have full prescriptive authority for FDA-approved weight-loss medications in all states, including GLP-1 agonists like Wegovy (semaglutide) and Saxenda (liraglutide). Ozempic (semaglutide for diabetes) can be prescribed off-label for weight loss in most states, though Mississippi specifically banned this practice in 2023. Ensure you follow your state’s obesity prescribing standards (BMI criteria, informed consent, follow-up requirements). Pursuing American Board of Obesity Medicine certification strengthens your scope-of-practice legitimacy.

Do I need extra certification to prescribe GLP-1 medications as a psychiatrist?

No formal certification is legally required, but additional training is strongly recommended. Many psychiatrists pursue the American Board of Obesity Medicine (ABOM) certification, which requires ~60 hours of obesity-related CME and passing a comprehensive exam. This demonstrates competency in obesity medicine and addresses any scope-of-practice concerns. At minimum, complete 20-30 hours of CME covering GLP-1 pharmacology, metabolic complications, and weight management protocols before adding these medications to your practice.

Can PMHNPs prescribe weight-loss medications independently?

It depends entirely on your state. In ~24 Full Practice Authority states (like Washington, Arizona, Maryland), experienced PMHNPs can prescribe independently. In reduced-practice states (like New York, Illinois after meeting hour thresholds), you need initial physician collaboration but may eventually gain independence. In restricted states (Texas, Florida, Pennsylvania, California), you ALWAYS need a physician collaborative agreement or supervising physician to prescribe weight-loss medications. Even in independent states, some insurers require physician involvement for high-cost GLP-1 prescriptions.

What are the telehealth rules for prescribing phentermine?

Federal law (DEA waivers through Dec 2025+) allows prescribing controlled substances like phentermine (Schedule IV) via telehealth without an initial in-person visit. However, state laws can be stricter. Florida explicitly prohibits prescribing ANY controlled substance via telehealth except for psychiatric disorders, inpatient care, or acute pain — weight loss isn’t included, so phentermine via telehealth is illegal in Florida. Alabama similarly requires in-person exams. About 8 states maintain stricter-than-federal rules. Always check your state’s specific telehealth controlled substance prescribing laws before writing phentermine remotely.

How much can I realistically earn from weight-loss medication management?

Conservative estimate for part-time practice: 10 new patients/month with 80% retention, average 3 visits per patient over 6 months. Initial visits reimburse ~$150 (CPT 90792 or 99204), follow-ups ~$100-120 (99213-214). By month 6, stabilized revenue: ~$5,000-6,000/month from weight management visits alone. Psychiatrists get 100% of physician fee schedule rates; PMHNPs typically 85% (or 100% in Illinois Medicaid). Using a pay-per-appointment platform model eliminates the $3,000-5,000/month marketing spend required for DIY patient acquisition, making this immediately profitable rather than requiring 6-12 months to break even.

What’s the biggest compliance mistake providers make with weight-loss prescribing?

Missing state-specific follow-up requirements. Florida mandates face-to-face visits every 3 months for patients on obesity medications — failing this triggers board investigations. Virginia requires 30-day follow-ups initially. Providers also get burned prescribing controlled substances via telehealth in states that prohibit it (Florida, Alabama) despite federal waivers allowing it elsewhere. Another common error: inadequate documentation — not recording BMI, skipping informed consent, failing to document lifestyle counseling. Regulators scrutinize weight-loss prescribing; sloppy documentation or ‘questionnaire-only’ prescribing without proper exam can result in license suspension.

Do I need a collaborating physician as an NP even in a full-practice state?

Legally, no — if you’re in a Full Practice Authority state and meet the experience/education requirements. However, practical barriers exist: some insurers and pharmacies hesitate to process high-cost GLP-1 prescriptions from NPs without physician involvement (internal policies, not laws). Some telehealth platforms require physician medical directors in every state regardless of NP autonomy to smooth credentialing and provide controlled substance oversight. In states with Corporate Practice of Medicine laws (California, Texas), even independent NPs may need physician-owned practice structures. For weight-loss specifically, having physician collaboration adds credibility and ensures regulatory compliance even when not strictly legally required.

How long does it take to get credentialed for telehealth weight-loss prescribing?

Through a platform like Klarity: 4-6 weeks for credentialing and onboarding, then you can start seeing patients immediately. DIY route: Insurance credentialing takes 90-120 days per panel (multiply by 5-10 panels for meaningful coverage). State medical/nursing license verification: 2-4 weeks. DEA registration in new state: 4-6 weeks. Telehealth platform setup: 1-2 weeks. ABOM certification if pursuing: 3-6 months of study plus exam scheduling. If you’re an NP in a restricted state, finding and contracting with a collaborative physician: 2-8 weeks. Total DIY timeline: 6-9 months before seeing first revenue. Platform route removes most of this friction.

What happens if Medicare coverage of GLP-1s changes my patient volume?

The late-2025 Medicare announcement covering anti-obesity medications will dramatically expand patient access. Expect 20-30% increase in weight management patient inquiries from Medicare beneficiaries (age 65+) starting in 2026. This is a massive opportunity: millions of seniors with obesity now have coverage for GLP-1s that previously cost $1,300/month out-of-pocket. You’ll need to handle prior authorizations (Medicare will require documented BMI, lifestyle interventions, medical necessity). Platforms like Klarity that already handle insurance credentialing and billing can absorb this volume surge; solo providers may need billing staff help. Revenue potential increases significantly with Medicare coverage expansion.

Is it worth pursuing ABOM certification as a psychiatrist?

If you’re serious about weight management as a significant part of your practice: yes. ABOM certification costs ~$1,500-2,000 (prep course + exam) and requires 60+ hours of CME, but it provides: (1) Documented competency addressing scope-of-practice concerns, (2) Deeper clinical knowledge (endocrine physiology, nutritional interventions, behavioral strategies), (3) Credibility with patients and referring providers, (4) Potential for higher reimbursement (some value-based contracts pay more for board-certified obesity specialists). If you’re only occasionally prescribing GLP-1s to existing psych patients with medication-induced weight gain, 20-30 hours of targeted CME may suffice. For launching a dedicated telehealth weight-loss service, ABOM certification is a smart investment that typically pays for itself within 3-4 months of increased patient volume.

Sources and References

1. MedicalDirector Co. – ‘How Much Does a Collaborative Physician Cost for Weight Loss, Telehealth, and Medspas? (2025 Definitive Guide)’ (2025) [Industry compliance analysis]

2. MedicalDirector Co. – ‘Florida Weight Loss Clinic and Telehealth Compliance Guide (2025)’ (Updated 2025) [State-specific regulatory guide]

3. MedicalDirector Co. – ‘Texas Weight Loss Clinic & Telehealth Compliance Guide (2025)’ (Updated 2025) [State-specific regulatory guide]

4. Florida Administrative Code Rule 64B15-14.004 – Standards for Prescription of Obesity Drugs (Effective Aug 8, 2022, current through 2026) [Official state regulation]

5. Mondaq/Foley & Lardner LLP – ‘A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ (July 24, 2023) [Legal industry analysis]

6. RxAgent.co – ‘Federal Permission, State Prohibition: The 2026 Telehealth Compliance Trap’ by PharmD analysis (Dec 16, 2025) [Pharmacy compliance insights]

7. The Nurse Practitioner Journal – ’36th Annual APRN Legislative Update: Improving Access Through APRN Practice Authority’ by Susanne J. Phillips (January 2024) [Peer-reviewed professional journal, state-by-state NP scope summary]

8. DrLewis.com – ‘Should Psychiatrists Prescribe GLP-1s? An Evidence-Based Perspective’ by Dr. Elliott Lewis, MD (Jan 4, 2026) [Psychiatrist expert analysis with clinical citations]

9. DrLewis.com – ‘GLP-1 Medications & Mental Health: Facts vs Myths’ by Dr. Elliott Lewis, MD (Nov 26, 2025) [Clinical evidence review]

10. Axios Health News – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024) [News confirming DEA/HHS policy extensions]

11. Axios – ‘Trump announces Medicare coverage of weight-loss drugs’ (Nov 6, 2025) [Policy announcement news coverage]

12. Associated Press – ‘Biden proposes Medicare and Medicaid cover costly weight-loss drugs’ (Nov 26, 2024) [Major policy development reporting]

13. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (2026 updated) [Billing guide with CPT code rates]

14. Blue Cross Blue Shield of Texas – Provider Notice on GLP-1 Supply Limit for Obesity (Oct 4, 2024) [Insurer coverage policy bulletin]

Source:

• https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/#:~:text=The%20answer%20is%20almost%20always,yes
• https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/#:~:text=Nurse%20Practitioners%20
• https://journals.lww.com/tnpj/fulltext/2024/01000/36thannualaprnlegislativeupdate__improving.6.aspx#:~:text=The%20Pennsylvania%20BON%20grants%20CRNPs%2C,more%20physicians%20to%20deliver%20healthcare
• https://journals.lww.com/tnpj/fulltext/2024/01000/36thannualaprnlegislativeupdate__improving.6.aspx#:~:text=The%20Illinois%20Department%20of%20Financial,collaborative%20agreement%20following%20a%20TTP
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20DEA%20gave%20us%20the,evaluation%20at%20the%20federal%20level
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=Despite%20federal%20DEA%20waivers%20extending,traps%20for%20digital%20health%20providers
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=1.%20Florida%3A%20The%20%22No,for%20Stimulants
• https://www.mondaq.com/unitedstates/healthcare/1447512/a-changing-regulatory-and-reimbursement-landscape-for-weight-loss-drugs#:~:text=New%20Jersey%20law%20requires%20that,and%20identify%20the%20risks%20associated
• https://drlewis.com/glp-1-medications-psychiatry/#:~:text=You%20know%20these%20drugs,disorders%2C%20and%20possibly%20depression%20itself
• https://drlewis.com/glp-1-mental-health/#:~:text=Now%20let%E2%80%99s%20talk%20about%20potential,where%20things%20get%20really%20interesting